1,708 results on '"FRANCO, Renato"'
Search Results
52. Extrapleural solitary fibrous tumor: A distinct entity from pleural solitary fibrous tumor. An update on clinical, molecular and diagnostic features
53. Double-staining Immunohistochemistry Reveals in Malignant Pleural Mesothelioma the Coexpression of ERCC1 and RRM1 as a Frequent Biological Event Related to Poorer Survival
54. The wide world of Portugal/ O imenso mundo de Portugal
55. Unveiling the unexplored: shedding light on a novel aspect of colorectal carcinoma.
56. Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype
57. COVID-19: detection methods in post-mortem samples
58. The Role of Toll-like Receptor-4 in Macrophage Imbalance in Lethal COVID-19 Lung Disease, and Its Correlation with Galectin-3
59. Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors
60. Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV
61. The Use of Portfolios to Foster Professionalism: Attributes, Outcomes, and Recommendations
62. Longstanding Eccrine Syringofibroadenoma With Evidence of Carcinomatous Transformation
63. Heterogeneity of PD-L1 Expression in Lung Mixed Adenocarcinomas and Adenosquamous Carcinomas
64. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity
65. Artificial Intelligence Applied to a First Screening of Naevoid Melanoma: A New Use of Fast Random Forest Algorithm in Dermatopathology
66. Case report of unusual synchronous anal and rectal squamous cell carcinoma: clinical and therapeutic lesson
67. Shortage of pathologists in Italy: survey of students and residents
68. Application of CytoMatrix for the diagnosis of melanoma metastases on FNA cytology samples: Performance of a novel cell block method
69. A Critical Issue in Lung Cancer Cytology and Small Biopsies: DNA and RNA Extraction from Archival Stained Slides for Biomarker Detection through Real Time PCR and NGS—The Experience in Pathological Anatomy Unit
70. NTRK gene aberrations in triple‐negative breast cancer: detection challenges using IHC, FISH, RT‐PCR, and NGS
71. BIOLAW, HUMAN RIGHTS AND BIOETHICS: NEEDS AND CHALLENGES IN THE CONTEMPORARY CONTEXTA
72. List of Contributors
73. Molecular Mechanisms in the Pathogenesis of Malignant Pleural Mesothelioma: Predictive and Prognostic Factors
74. Correction to: The Mediastinal Mass
75. A teoría crítica de Roberto Schwarz. Uma introduçao
76. PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype
77. Data from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis
78. Video from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis
79. RERF Conformational Preferenc from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis
80. Dattabase Information from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis
81. Supplementary Data to Figure 3 from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis
82. Video Description from Structure-based design of an urokinase-type plasminogen activator receptor–derived peptide inhibiting cell migration and lung metastasis
83. Supplementary Figure 7 from Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer
84. Supplementary Figure 2 from Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer
85. Supplementary Figure 5 from Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer
86. Supplementary Methods, Figure Legends 1-7, Table Legend 1 from Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer
87. Data from Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer
88. Supplementary Figure 4 from Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer
89. Supplementary Figure 6 from Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer
90. Supplementary Figure 1 from Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer
91. Supplementary Figure 3 from Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer
92. Primary Cutaneous B-Cell Lymphomas with Large Cell Morphology: A Practical Review
93. Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types
94. The prognostic value of histopathology in invasive lung adenocarcinoma: a comparative review of the main proposed grading systems
95. To get the most out of the least: BRAF molecular evaluation in melanoma metastases on cell suspension from fine needle aspiration cytology (FNAC) needle rinses.
96. Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides
97. Water productivity using SAFER--simple algorithm for evapotranspiration retrieving in watershed/Produtividade da agua estimada pelo SAFER--Simple Algorithm for evapotranspiration retrieving em bacia hidrografica
98. Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study
99. Cutaneous Squamous Cell Carcinoma: Focus on Biochemical and Molecular Characteristics
100. Basal Cell Carcinoma: Molecular and Pathological Features
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.